Abbeduto, Leonard
Thurman, Angela John
McDuffie, Andrea
Klusek, Jessica
Feigles, Robyn Tempero
Ted Brown, W.
Harvey, Danielle J.
Adayev, Tatyana
LaFauci, Giuseppe
Dobkins, Carl
Roberts, Jane E.
Funding for this research was provided by:
National Institute of Child Health and Human Development (R01HD024356, U54HD079125)
Article History
First Online: 31 October 2018
Compliance with Ethical Standards
:
: Leonard Abbeduto has received funding to develop and implement outcome measures for clinical trials from F. Hoffman-LaRoche, Ltd., Roche TCRC, Inc., Neuren Pharmaceuticals Limited, and Fulcrum Therapeutics, Inc. W. Ted Brown and Giuseppe LaFauci hold a patent for a measure used in this study [System and Method for Quantifying Fragile X Mental 1 Protein in tissue and blood samples (United States Patent # 8628934)], with the assignee for the patent being the Research Foundation for Mental Hygiene, Inc. No other authors have conflicts or financial disclosures to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All authors obtained review and approval from the Institutional review boards of their respective universities/institutions. This article does not contain any studies with animals performed by any of the authors.
: was obtained from all individual participants included in the study or from their legally authorized representatives.